CINECA IRIS Institutional Research Information System

CONTI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.401
EU - Europa 3.098
AS - Asia 1.849
SA - Sud America 58
AF - Africa 49
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.294
CN - Cina 1.099
IT - Italia 1.020
SE - Svezia 370
IE - Irlanda 307
DE - Germania 257
FR - Francia 224
UA - Ucraina 141
SG - Singapore 139
DK - Danimarca 133
FI - Finlandia 129
KR - Corea 126
GB - Regno Unito 106
AT - Austria 101
JP - Giappone 91
PL - Polonia 91
VN - Vietnam 85
IN - India 72
CA - Canada 56
HK - Hong Kong 44
BE - Belgio 42
TR - Turchia 42
MX - Messico 41
SN - Senegal 38
IR - Iran 36
AU - Australia 34
TW - Taiwan 29
ES - Italia 25
BR - Brasile 24
RU - Federazione Russa 22
GR - Grecia 21
NL - Olanda 20
PT - Portogallo 19
ID - Indonesia 17
CZ - Repubblica Ceca 13
CL - Cile 12
CH - Svizzera 11
HU - Ungheria 11
TH - Thailandia 10
MY - Malesia 9
CU - Cuba 8
EC - Ecuador 8
NO - Norvegia 8
PK - Pakistan 8
RO - Romania 7
CO - Colombia 6
IL - Israele 6
PE - Perù 6
EG - Egitto 5
LT - Lituania 5
SA - Arabia Saudita 5
BG - Bulgaria 4
EU - Europa 4
BD - Bangladesh 3
CY - Cipro 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
PH - Filippine 3
UZ - Uzbekistan 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AR - Argentina 1
BT - Bhutan 1
ET - Etiopia 1
GE - Georgia 1
IQ - Iraq 1
JO - Giordania 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.494
Salva come PNG Salva come JPEG
Città #
Chandler 611
Fairfield 371
Torino 332
Beijing 330
Dublin 306
Houston 255
Ashburn 222
Ann Arbor 196
Wilmington 185
Cambridge 167
Woodbridge 163
Turin 151
Seattle 125
Nyköping 115
Dearborn 106
Vienna 96
Villeurbanne 92
Jacksonville 89
Princeton 86
Medford 84
Singapore 84
Redwood City 80
Pisa 77
Warsaw 75
Shanghai 74
Milan 57
Guangzhou 55
Nanjing 53
Hangzhou 49
Dong Ket 41
Boston 35
Fremont 29
Chengdu 28
New York 28
Washington 27
Xian 25
Brussels 24
Changsha 24
Wuhan 24
Boardman 23
Ottawa 23
Taipei 23
Zhengzhou 22
Helsinki 19
Rome 19
San Diego 19
Padova 18
Seoul 18
Shenyang 18
Chongqing 17
Hong Kong 17
Jinan 17
Hyderabad 16
Munich 16
Silver Spring 16
Tokyo 15
Chennai 14
Istanbul 14
Phoenix 14
Tianjin 14
Hefei 13
Los Angeles 12
Düsseldorf 11
Falls Church 11
Hebei 11
Norwalk 11
Ankara 10
Athens 10
Kharkiv 10
Villa Bartolomea 10
Chicago 9
Duncan 9
Kunming 9
Parma 9
Toronto 9
Verona 9
Delhi 8
Ecatepec 8
La Habana 8
London 8
Melbourne 8
Sydney 8
Upper Marlboro 8
Vigliano Biellese 8
Central District 7
Changchun 7
Harbin 7
Moscow 7
San Mateo 7
Trieste 7
Amsterdam 6
Buffalo 6
Central 6
Cisternino 6
Dresden 6
Frankfurt am Main 6
Fuzhou 6
Gravina In Puglia 6
Jakarta 6
Kuala Lumpur 6
Totale 5.672
Salva come PNG Salva come JPEG
Nome #
Breast cancer stem cell antigens as targets for immunotherapy 890
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter 429
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells 386
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging 338
NK cells control breast cancer and related cancer stem cell hematological spread 294
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer 247
Multi-level model for the investigation of oncoantigen- driven vaccination effect 236
A mathematical-biological joint effort to investigate the tumor-initiating ability of cancer stem cells. 225
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 209
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells 204
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer 204
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 197
RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells 191
Cancer stem cell antigens as targets for new combined anti-cancer therapies 178
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo 163
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice 158
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents 156
Water Soluble Melanin Derivatives for Dynamic Contrast Enhanced Photoacoustic Imaging of Tumor Vasculature and Response to Antiangiogenic Therapy 148
In Human Multiple sclerosis, T helper 17 lymphocytes display increased levels of JAK2 that stabilize cell surface IFN-YR2chain 146
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells 137
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 134
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy 130
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis 124
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 120
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential 117
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy 115
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 115
B7h triggering inhibits the migration of tumor cell lines. 110
Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice 110
Multiple Roles of Perforin in Hampering ERBB-2 (Her-2/neu) Carcinogenesis in Transgenic Male Mice 109
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 108
Multi-level model for the investigation of oncoantigen-driven vaccination effect 107
Cancer Stem Cell based adjuvant for oncoantingen-driven vaccination 102
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota 99
Iron regulates T-lymphocyte sensitivity to the IFN-gamma/STAT1 signaling pathway in vitro and in vivo. 96
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma 93
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 91
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 88
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies 86
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 85
TYPE 1 INTERFERON RECEPTOR (IFNA-R1). EXPRESSING TH17 LYMPHOCYTES ARE INCREASED DURING MS RELAPSES AND ARE SELECTIVELY INTHBITED BY IFNβ 83
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial 76
A new optical imaging probe targeting α(V) β(3) integrin in glioblastoma xenografts. 75
T helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β 73
B7h triggering inhibits the migration of tumor cell lines x 73
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas 73
Th17, an effector T Lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon beta 72
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis 72
T-helper 17 lymphocytes during MS relapses: antigen specificity and cytokine production. A multicentre longitunal study 70
B7H triggering inhibits migration of tumor cell lines 70
IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes 66
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growth 65
Flow Cytometry for Beginners: Hints and Tips for Approaching the Very First Single-Cell Technique 65
Th17 lymphocytes are expandend in multiple sclerosis and are inhibited by interferon beta 64
T-helper 17 lymphocytes increase during multiple sclerosis relapses and are inhibited by interferon beta 64
Iron regulates T lymphocyte sensitivity to the IFN-g/STAT1 signaling pathway in vitro and in vivo 63
IL- 17 and IL-22 producing increased in multiple sclerosis relapses are MBP-specific. A multi-centre longitudinal study 62
T helper 17 Lymphocytes and multiple sclerosis: their increase in active phases of disease and the interferon beta induced inhibition 62
Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe bindingαvβ3integrins 60
Retrovirus-mediated targeting of the Insulin-like Growth Factor-1 Receptor reinstates T lymphocytes sensitivity to the apoptotic effect of IFN-g 59
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 59
In T lymphocytes, ablation of STAT3 expression reinstates STAT1-dependent apoptosis by both IFNg and IL-6 58
Ready for a new saga? Th17 and not Th1 are selectively increased in active multiple sclerosis and undergo apoptosis with interferon beta 57
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 57
In the absence of Insulin-like Growth Factor (IGF)-1 signaling, Interferon-gamma (IFN-g) inhibits the growth of human malignant T cells 54
JAK2 is overexpressed in human multiple sclerosis Th17 cells andstabilizes cell surface expression of IFN-gammaR2. 53
MBP-Specific Th17 Lymphocytes selectively increase during MS relapses. A multicenter longitudinal Study 52
Iron chelation restores human T cells sensitivity to the IFN-g/STAT1 signaling pathway. Jaks and Stats: development to disease 51
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy? 51
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. 49
Interleukin-17 t lymphocyte production correlates with disease activity in Multiple Sclerosis 48
Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model. 48
Ready for a new saga? Th17 and not Th1 are selectivly increate in active multiple sclerosis and undergo apoptosis with interferon beta 43
T-helper 17 lymphocytes during MS relapses: antigen specifity and cytokine production. A multicentre longitudinal sudy 42
The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells 42
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing 40
Longitudinal analysis of IL-17 and/or IL-22 producing CD4+ T lymphocytes in relapsing remitting multiple sclerosis 39
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 37
The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy 35
Tissue memory relies on stem cell priming in distal undamaged areas 34
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy 31
JAK2 is overexpressed in human multiple sclerosis Th17 cells and stabilizes cell surface expression of IFN-gammaR2 31
Modulation of STAT1 signaling pathway by Interferons (IFNs) in human T helper (Th)17 lymphocytes 28
A Magnetic Resonance Imaging‐Chemical Exchange Saturation Transfer (MRI‐CEST) Method for the Detection of Water Cycling across Cellular Membranes 23
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models 20
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 20
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment 18
A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation 15
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models 14
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source 14
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease 12
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy 11
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer 6
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine 3
Totale 9.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.541
article - articoli 0
book - libri 0
conference - conferenze 4.746
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.287
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.371 0 76 97 170 99 228 140 114 151 133 90 73
2020/20211.361 80 69 88 63 98 89 144 79 180 150 133 188
2021/20221.651 100 93 82 155 109 111 110 102 79 183 267 260
2022/20231.918 195 146 53 187 139 458 155 145 179 49 134 78
2023/20241.244 130 153 108 87 114 129 93 88 18 95 113 116
2024/202597 71 26 0 0 0 0 0 0 0 0 0 0
Totale 9.837